Dimethylformamide → HCID 58919238, compound
Reaction equation
N(C([C:6]1[C:7]([F:27])=[C:8]([CH:23]=[CH:24][C:25]=1[F:26])[CH2:9][N:10]1[CH2:15][CH2:14][N:13]([C:16]([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17])[CH2:12][CH2:11]1)=O)=[N+]=[N-].[CH3:28][C:29]1[N:34]=[CH:33][C:32]([NH2:35])=[CH:31][CH:30]=1.C[N:37]([CH:39]=[O:40])C>CCOC(C)=O>[F:27][C:7]1[C:6]([NH:37][C:39]([NH:35][C:32]2[CH:33]=[N:34][C:29]([CH3:28])=[CH:30][CH:31]=2)=[O:40])=[C:25]([F:26])[CH:24]=[CH:23][C:8]=1[CH2:9][N:10]1[CH2:15][CH2:14][N:13]([C:16]([O:18][C:19]([CH3:22])([CH3:20])[CH3:21])=[O:17])[CH2:12][CH2:11]1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of tert-butyl 4-(3-(azidocarbonyl)-2,4-difluorobenzyl)piperazine-1-carboxylate (2.52 g, nominally 5.4 mmol, 1.0 equiv) and 6-methylpyridin-3-amine (389 mg, 3.6 mmol, 0.66 equiv) in 7 mL of DMF was stirred at room temperature over 72 h, after which, the reaction mixture was diluted with EtOAc and washed repeatedly with water. After the EtOAc layer was washed with aq. satd. NaHCO3 and brine, it was dried over sodium sulfate, filtered and concentrated in vacuo. Reverse phase chromatography provided tert-butyl 4-(2,4-difluoro-3-(3-(6-methylpyridin-3-yl)ureido)benzyl)piperazine-1-carboxylate (800 mg, 32% over 4 steps). LCMS m/z (APCI)=462.2 (M+H).
Workup
- washwashed repeatedly with water
- washAfter the EtOAc layer was washed with aq. satd
- dry with materialNaHCO3 and brine, it was dried over sodium sulfate
- filtrationfiltered
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-bc5e8bbb87ad4f7c9492bf784c8e82a6
- Source dataset
- uspto-grants-2014_10
- Patent number
- US08871768B2
Reaction notes
Loading…